TXG - +33% Upside with 1:2 RRBreakout of key resistance level.
Momentum building.
Trend reversal that is on the verge of a pop off.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.53 USD
−255.10 M USD
618.73 M USD
100.14 M
About 10x Genomics, Inc.
Sector
Industry
CEO
Serge Saxonov
Website
Headquarters
Pleasanton
Founded
2012
FIGI
BBG007WX14X0
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
TGX.NYSE 10X Genomics Trend Cloud Study Potential 100% Upside.10X Genomics Trend Cloud Study shows a Potential 100% Upside.
This Ticker is way oversold and a Double Bottom is Seen.
Very Risky and Speculative. I'm Nibbling a few $100.
As always, please get a few outside Expert's Advice before making Trade or Investment Decisions.
Should you appreciate my Ch
7/10/24 - $txg - Small swing, mid $15s7/10/24 :: VROCKSTAR :: NASDAQ:TXG
Small swing, mid $15s
- Illumina buying Fluent matters
- Have been skeptical of financials on NASDAQ:TXG for some time (and it's a Cathie owned name which has kept me even more discerning)
- Still have a tough time justifying valuation mainly bc cash burner an
TXG possible reversalOversold on the daily, Filled Gap from Nov 2023, Risk is todays low 35.42. Rsi curl .
PT is open, had previous support at 40.40 which would be 1st resistance , SMA or fib levels also
TXG approaching support zonesAnticipating support in these zones wont hurt. Keeping strict stop loss and following long trade has a higher probability to win
Best stock to buy nowBest stock to buy now - 23.05.2023
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genom
TXG Healthcare name we are shortA small position is suggested due to our stance on Healthcare being bullish and also the R isn't quite at 2.00 as of yet.
10X Genomics, Inc - Bullish divergenceOn the above 6-day chart price action has corrected 75% since the sell signal back in November 2020. A number of reasons now exist to be long, including:
1) Double ‘incredible buy’ signals. Awesome.
2) Price action and RSI resistance breakouts.
3) Price action is arrested by past support / resist
14/4/2022 NASDAQ (TXG)Short (Entry Price) within the sell zone area and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price.
Entry Price: $68.33 / $70.99
Target Price: $65.60 / $69.04
Stop Loss: $72.94
10x Genomics (NASDAQ: $TXG) Looks Ready For Growth! 🍄10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluid
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TXG is 16.78 USD — it has increased by 2.76% in the past 24 hours. Watch 10x Genomics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 10x Genomics, Inc. stocks are traded under the ticker TXG.
TXG stock has risen by 6.95% compared to the previous week, the month change is a −15.59% fall, over the last year 10x Genomics, Inc. has showed a −53.39% decrease.
We've gathered analysts' opinions on 10x Genomics, Inc. future price: according to them, TXG price has a max estimate of 30.00 USD and a min estimate of 14.00 USD. Watch TXG chart and read a more detailed 10x Genomics, Inc. stock forecast: see what analysts think of 10x Genomics, Inc. and suggest that you do with its stocks.
TXG stock is 5.71% volatile and has beta coefficient of 1.52. Track 10x Genomics, Inc. stock price on the chart and check out the list of the most volatile stocks — is 10x Genomics, Inc. there?
Today 10x Genomics, Inc. has the market capitalization of 2.03 B, it has increased by 6.59% over the last week.
Yes, you can track 10x Genomics, Inc. financials in yearly and quarterly reports right on TradingView.
10x Genomics, Inc. is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
TXG earnings for the last quarter are −0.30 USD per share, whereas the estimation was −0.33 USD resulting in a 8.72% surprise. The estimated earnings for the next quarter are −0.29 USD per share. See more details about 10x Genomics, Inc. earnings.
10x Genomics, Inc. revenue for the last quarter amounts to 151.65 M USD, despite the estimated figure of 156.89 M USD. In the next quarter, revenue is expected to reach 153.37 M USD.
TXG net income for the last quarter is −35.75 M USD, while the quarter before that showed −37.90 M USD of net income which accounts for 5.66% change. Track more 10x Genomics, Inc. financial stats to get the full picture.
No, TXG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 1.26 K employees. See our rating of the largest employees — is 10x Genomics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 10x Genomics, Inc. EBITDA is −133.38 M USD, and current EBITDA margin is −25.58%. See more stats in 10x Genomics, Inc. financial statements.
Like other stocks, TXG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 10x Genomics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 10x Genomics, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 10x Genomics, Inc. stock shows the sell signal. See more of 10x Genomics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.